Now showing items 1-2 of 2

    • Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study 

      O'Ryan Gallardo, Miguel; Bandyopadhyay, Ananda S.; Villena Martínez, Rodolfo; Espinoza Barrios, Mónica; Novoa, José; Weldon, William C.; Oberste, Steven; Self, Steve; Borate, Bhavesh R.; Asturias, Edwin J.; Clemens, Ralf; Orenstein, Walter; Jimeno, José; Ruettimann, Ricardo; Costa Clemens, Sue Ann (Elsevier, 2015)
      Background Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one dose of inactivated poliovirus vaccine ...
    • Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis 

      Ruiz Palacios, Guillermo M.; Pérez Schael, Irene; Velázquez, F. Raúl; Abate, Héctor; Breuer, Thomas; Costa Clemens, SueAnn; Cheuvart, Brigitte; Espinoza, Félix; Gillard, Paul; Innis, Bruce L.; Cervantes, Yolanda; Linhares, Alexandre C.; López, Pío; Macías Parra, Mercedes; Ortega Barría, Eduardo; Richardson, Vesta; Rivera Medina, Doris Maribel; Rivera, Luis; Salinas, Belén; Pavia Ruz, Noris; Salmerón, Jorge; Rüttimann, Ricardo; Tinoco, Juan Carlos; Rubio, Pilar; Núñez, Ernesto; Guerrero, Lourdes; Yarzábal, Juan Pablo; Damaso, Silvia; Tornieporth, Nadia; Sáez Llorens, Xavier; Vergara, Rodrigo F.; Vesikari, Timo; Bouckenooghe, Alain; Clemens, Ralf; De Vos, Béatrice; O'Ryan Gallardo, Miguel (Massachusetts Medical Soc, 2006-01-05)
      BACKGROUND: The safety and efficacy of an attenuated G1P[8] human rotavirus (HRV) vaccine were tested in a randomized, double-blind, phase 3 trial. METHODS: We studied 63,225 healthy infants from 11 Latin American ...